Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Bone Therapeutics reports half year 2021 results

  • Read more about Bone Therapeutics reports half year 2021 results

Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer

  • Read more about Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer

Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)

  • Read more about Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)

Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development

  • Read more about Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development

Bone Therapeutics Provides Third Quarter 2021 Business Update

  • Read more about Bone Therapeutics Provides Third Quarter 2021 Business Update

Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

  • Read more about Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement

  • Read more about Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement

Bone Therapeutics announces closing of private placement

  • Read more about Bone Therapeutics announces closing of private placement

Bone Therapeutics: Information on the total number of voting rights and shares

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares

Transparency notification received from Nyenburgh Holding NV

  • Read more about Transparency notification received from Nyenburgh Holding NV

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions